Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 08 Jan 2016 for Acadia Pharmaceuticals INC. Read the official filing
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
2
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- +20.6%Entry US$27.11 · Close at T+365 US$32.69
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
14159, L.P.: trading record in brief
All filings by 14159, L.P. on record concern Acadia Pharmaceuticals Inc. We count 2 filings, every one of them for a trade on 7 January 2016.
Purchases make up the whole of the open-market record (2 purchases). The totals do not cover 2 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The latest filing, published on 8 January 2016, reports an open-market purchase in Acadia Pharmaceuticals Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to 14159, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
785,045 sharesCommon StockSEC:0001638599-16-000500:0
Canonical exit: 6 Apr 2016 (T+90)
1,801,161 sharesCommon StockSEC:0001638599-16-000500:1
Canonical exit: 6 Apr 2016 (T+90)
2 of 2 declarations
